Dr. Alec James Redwood is head of the vaccine and viral immunity laboratory at the University of Western Australia (UWA). Dr. Redwood holds a PhD (awarded in 1997) from Curtin University. From 2018, he has held the position of Principal Research Fellow at the Institute for Respiratory Health, UWA. Prior to this (2014–2018), he was an Associate Professor in Immunology at the Institute for Immunology and Infectious Diseases, Murdoch University. From 2001 to 2014, he was a Research Fellow in the Department of Microbiology, UWA. For the majority of his career, he has focused on vaccine design and viral mechanisms of immunomodulation. He has a specific focus on the use of murine cytomegalovirus as a vaccine vector. Dr. Redwood also has a strong focus on T-cell immunity to a range of antigens. He has led studies investigating T-cell immunity to a highly diverse array of antigens, including herpesviruses (HSV and EBV), tumors (tumor immunology), and small drug molecules (drug hypersensitivity). Dr. Redwood is a long-standing member of the Australasian Society for Immunology and a past state councillor of this organization.
Dr. Alec James Redwood is head of the vaccine and viral immunity laboratory at the University of Western Australia (UWA). Dr. Redwood holds a PhD (awarded in 1997) from Curtin University. From 2018, he has held the position of Principal Research Fellow at the Institute for Respiratory Health, UWA. Prior to this (2014–2018), he was an Associate Professor in Immunology at the Institute for Immunology and Infectious Diseases, Murdoch University. From 2001 to 2014, he was a Research Fellow in the Department of Microbiology, UWA. For the majority of his career, he has focused on vaccine design and viral mechanisms of immunomodulation. He has a specific focus on the use of murine cytomegalovirus as a vaccine vector. Dr. Redwood also has a strong focus on T-cell immunity to a range of antigens. He has led studies investigating T-cell immunity to a highly diverse array of antigens, including herpesviruses (HSV and EBV), tumors (tumor immunology), and small drug molecules (drug hypersensitivity). Dr. Redwood is a long-standing member of the Australasian Society for Immunology and a past state councillor of this organization.